Skip to main content
Caplight Logo









Nobio

Nobio

Private
IsraelHealthcare & Life Scienceshttps://www.nobio.com/

Last Round

Grant

Apr 9, 2020

Total Funding Raised

$6.55M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Nobio is a biotechnology company that develops long-term antibacterial and antiviral solutions for medical, dental, and consumer products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share

AI Layer

Non-AI

Keywords

antimicrobial technologydental restorative materialsQASi particle technologytechnology licensingdental compositesnon-leaching antimicrobialsecondary caries preventionbioactive materialsantimicrobial additivesmaterials sciencemedical device materialsingredient brandingFDA cleared medical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nobio Comparables

Compare Nobio with similar companies based on industry and business-model similarity.

Nobio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pulpdent Corporation
79%
FiteBac Dental
79%
Mesosil
78%

Nobio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 9, 2020
GrantMay 1, 2019
SeedJul 30, 2018

Key People

Founding team and executive leadership

Natan Zaltsman

Chief Technology Officer

Executive Team

Nobio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 71% MoM, reaching 3K.

  • Jul 26, 2026

    Monthly visitors grew 35% MoM, reaching 1.8K.

Nobio Filings

Explore SEC and related filing metadata, where available.

Nobio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nobio's valuation, stock price, and market status.

Is Nobio a public or private company?

Nobio is a private company.

What is the current stock price of Nobio?

Nobio is a private company with no public stock price. No recent secondary market data is available.

How much is Nobio worth (valuation)?

Valuation information for Nobio is not publicly available.

Can I buy Nobio stock?

Nobio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nobio's last funding round?

Nobio's most recent funding round was Grant on April 9, 2020.

Who are the main investors in Nobio?

Key investors in Nobio include aMoon.

Will Nobio IPO soon?

No public IPO plans have been announced for Nobio.

How can I track Nobio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nobio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range13
Year Founded2015
Last FundingApr 9, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?